Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Clinicopathological presentations and surgical outcomes of esophageal melanoma.

Urabe M, Haruta S, Ohkura Y, Inoshita N, Yago A, Koga S, Tanaka T, Ueno M, Udagawa H.

Asian Cardiovasc Thorac Ann. 2019 Sep;27(7):548-553. doi: 10.1177/0218492319866064. Epub 2019 Jul 18. No abstract available.

PMID:
31319672
2.

Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy.

Yamashita K, Watanabe M, Mine S, Kurogochi T, Okamura A, Hayami M, Imamura Y.

World J Surg. 2017 Sep;41(9):2337-2344. doi: 10.1007/s00268-017-4024-5.

PMID:
28432391
3.

Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy.

Hiyoshi Y, Morita M, Kawano H, Otsu H, Ando K, Ito S, Miyamoto Y, Sakamoto Y, Saeki H, Oki E, Ikeda T, Baba H, Maehara Y.

Ann Surg Oncol. 2015 Jan;22(1):240-6. doi: 10.1245/s10434-014-3970-5. Epub 2014 Aug 15.

PMID:
25124469
4.

Surgical treatment for esophageal cancer. Current issues.

Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Kuwano H.

Dig Surg. 2007;24(2):88-95. Epub 2007 Apr 19. Review.

5.

Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.

Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Sakamoto Y, Miyamoto Y, Kurashige J, Kosumi K, Tokunaga R, Watanabe M, Baba H.

Int J Clin Oncol. 2016 Dec;21(6):1071-1078. Epub 2016 Jun 2.

PMID:
27255393
6.

Late Recurrence After Radical Resection of Esophageal Cancer.

Hiyoshi Y, Yoshida N, Watanabe M, Kurashige J, Karashima R, Iwagami S, Baba Y, Baba H.

World J Surg. 2016 Apr;40(4):913-20. doi: 10.1007/s00268-015-3334-8.

PMID:
26552914
7.

Clinicopathological Features of Cervical Esophageal Cancer: Retrospective Analysis of 63 Consecutive Patients Who Underwent Surgical Resection.

Saeki H, Tsutsumi S, Yukaya T, Tajiri H, Tsutsumi R, Nishimura S, Nakaji Y, Kudou K, Akiyama S, Kasagi Y, Nakashima Y, Sugiyama M, Sonoda H, Ohgaki K, Oki E, Yasumatsu R, Nakashima T, Morita M, Maehara Y.

Ann Surg. 2017 Jan;265(1):130-136. doi: 10.1097/SLA.0000000000001599.

PMID:
28009737
8.

Unusual malignant neoplasms of the esophagus. Oat cell carcinoma, melanoma, and sarcoma.

Caldwell CB, Bains MS, Burt M.

J Thorac Cardiovasc Surg. 1991 Jan;101(1):100-7.

PMID:
1702494
9.

The port site recurrence after a thoracoscopic and video-assisted esophagectomy for advanced esophageal cancer.

Yamamoto S, Kawahara K, Maekawa T, Shiraishi T, Shirakusa T.

J Thorac Oncol. 2009 Jan;4(1):131-4. doi: 10.1097/JTO.0b013e31818e5ebc.

10.

Clinicopathological characteristics and prognosis of patients with esophageal carcinoma invading adjacent structures found during esophagectomy.

Kosugi S, Ichikawa H, Kanda T, Yajima K, Ishikawa T, Hatakeyama K.

J Surg Oncol. 2012 Jun 15;105(8):767-72. doi: 10.1002/jso.22092. Epub 2012 Apr 2.

PMID:
22473575
11.

Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.

Xue LY, Qin XM, Liu Y, Liang J, Lin H, Xue XM, Zou SM, Zhang MY, Zhang BH, Hui ZG, Zhao ZT, Ren LQ, Zhang YM, Liu XY, Yuan YL, Ying JM, Gao SG, Song YM, Wang GQ, Dawsey SM, Lu N.

World J Gastroenterol. 2018 Dec 7;24(45):5154-5166. doi: 10.3748/wjg.v24.i45.5154.

12.

Primary malignant melanoma of the esophagus treated with subtotal esophagectomy: a case report.

Kuwabara S, Ebihara Y, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S.

BMC Surg. 2017 Dec 2;17(1):122. doi: 10.1186/s12893-017-0326-7.

13.

The prognostic factors after radical esophagectomy for esophageal cancer with positive preoperative CEA.

Takemura M, Osugi H, Takada N, Okuda E, Ueno M, Kinoshita H.

Hepatogastroenterology. 2004 Jan-Feb;51(55):159-62.

PMID:
15011854
14.

[Primary malignant melanoma of the esophagus].

Khoury-Helou A, Lozac'h C, Vandenbrouke F, Lozac'h P.

Ann Chir. 2001 Jul;126(6):557-60. French.

PMID:
11486540
15.

Patterns and time of recurrence after complete resection of esophageal cancer.

Sugiyama M, Morita M, Yoshida R, Ando K, Egashira A, Takefumi O, Saeki H, Oki E, Kakeji Y, Sakaguchi Y, Maehara Y.

Surg Today. 2012 Aug;42(8):752-8. doi: 10.1007/s00595-012-0133-9. Epub 2012 Feb 28.

PMID:
22370963
16.

Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients.

Sohda M, Saito H, Kuriyama K, Yoshida T, Kumakura Y, Honjyo H, Hara K, Ozawa D, Suzuki S, Tanaka N, Sakai M, Miyazaki T, Fukuchi M, Kuwano H.

In Vivo. 2019 Mar-Apr;33(2):501-506. doi: 10.21873/invivo.11502.

17.

Local recurrence after total or subtotal esophagectomy for esophageal cancer.

Blewett CJ, Miller JD, Ramlawi B, Young JE, BennettWF, Urschel JD.

J Exp Clin Cancer Res. 2001 Mar;20(1):17-9.

PMID:
11370823
18.

Patterns of care and survival outcomes in the treatment of esophageal melanoma.

Weiner JP, Shao M, Schwartz D, Wong A, Schreiber D.

Dis Esophagus. 2017 Feb 1;30(2):1-6. doi: 10.1111/dote.12504.

PMID:
27862623
19.

Classification of recurrent esophageal cancer after radical esophagectomy with two- or three-field lymphadenectomy.

Kato H, Fukuchi M, Miyazaki T, Nakajima M, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Kuwano H.

Anticancer Res. 2005 Sep-Oct;25(5):3461-7.

20.

Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection.

Berry MF, Zeyer-Brunner J, Castleberry AW, Martin JT, Gloor B, Pietrobon R, D'Amico TA, Worni M.

J Thorac Oncol. 2013 Jun;8(6):796-802. doi: 10.1097/JTO.0b013e3182897bf1.

Supplemental Content

Support Center